Your browser doesn't support javascript.
loading
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.
Lodrini, Marco; Graef, Josefine; Thole-Kliesch, Theresa M; Astrahantseff, Kathy; Sprüssel, Annika; Grimaldi, Maddalena; Peitz, Constantin; Linke, Rasmus B; Hollander, Jan F; Lankes, Erwin; Künkele, Annette; Oevermann, Lena; Schwabe, Georg; Fuchs, Jörg; Szymansky, Annabell; Schulte, Johannes H; Hundsdörfer, Patrick; Eckert, Cornelia; Amthauer, Holger; Eggert, Angelika; Deubzer, Hedwig E.
Afiliação
  • Lodrini M; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Graef J; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Thole-Kliesch TM; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Astrahantseff K; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Sprüssel A; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Grimaldi M; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Peitz C; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Linke RB; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Hollander JF; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Lankes E; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Künkele A; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Oevermann L; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Schwabe G; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Fuchs J; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Szymansky A; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Schulte JH; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Hundsdörfer P; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Eckert C; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Amthauer H; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Eggert A; Department of Pediatric Endocrinology and Diabetes, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Deubzer HE; Center for Chronically Sick Children, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Clin Cancer Res ; 28(9): 1809-1820, 2022 05 02.
Article em En | MEDLINE | ID: mdl-35247920

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / DNA Tumoral Circulante / Neuroblastoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / DNA Tumoral Circulante / Neuroblastoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article